Michael P. Abbott - 15 Apr 2022 Form 4 Insider Report for Owlet, Inc. (OWLT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Apr 2022, 20:31:59 UTC
Prior SEC filing
25 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jacob Briem, Attorney-in-Fact

Key filing fact

Michael P. Abbott filed Form 4 for Owlet, Inc. (OWLT) on 19 Apr 2022.

Key facts

  • This page summarizes Michael P. Abbott's Form 4 filing for Owlet, Inc. (OWLT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Apr 2022, 20:31.

Change

  • Previous filing in this sequence was filed on 25 Mar 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OWLT transaction

Common Stock

Award

Transaction value
$0
Shares
+17,744
Change %
+3.4%
Price
$0.000000
Shares after
544,060
Date
15 Apr 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on April 15, 2023, subject to the Reporting Person's continued service to the Issuer through such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .